While fructose itself is mostly oxidized or converted to glucose, its regulatory effects promote glycogen deposition, lipogenesis, and insulin resistance, linking high dietary fructose intake to increased risk of MASLD. This evidence concerns the gene INS and metabolic dysfunction-associated steatotic liver disease.